Description
This project will support process and assay development efforts currently ongoing at the NRC for an adeno-associated virus (AAV)-based next generation LPLD gene therapy. The goal of this project will be to accelerate the rate at which this …
Amendment chain · 4 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $355,921 at start, $637,634 after amendment #4 (+$281,713).
- #12022-12-01$355,921
- #22023-03-20$355,921
- #32023-12-21$637,634+$281,713
- #42024-11-25$637,634
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2022-12-01 | $355,921 | — | This project will support process and assay development efforts currently ongoing at the NRC for an adeno-asso… |
| #2 amendment | 2023-03-20 | $355,921 | +$0 | This project will support process and assay development efforts currently ongoing at the NRC for an adeno-asso… |
| #3 amendment | 2023-12-21 | $637,634 | +$281,713 | This project will support process and assay development efforts currently ongoing at the NRC for an adeno-asso… |
| #4 amendment | 2024-11-25 | $637,634 | +$0 | This project will support process and assay development efforts currently ongoing at the NRC for an adeno-asso… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 886822212)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2025-2026-Q4-1040276 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program – Ideation Fund | $25,000 | FY2026 |
| 033-2025-2026-Q4-515729 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · Life Sciences Fund | $880,950 | FY2026 |
| 033-2025-2026-Q4-515730 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · Life Sciences Fund | $1,246,250 | FY2026 |
| 207-2024-2025-Q4-00557 | Social Sciences and Humanities Research Council of Canada | Conseil de recherches en sciences humaines du Canada · New Frontiers in Research Fund | $246,389 | FY2025 |
| 172-2024-2025-Q4-1028951 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program – Ideation Fund | $25,000 | FY2025 |
| 172-2024-2025-Q3-1023387 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives | $887,131 | FY2025 |
Other recipients funded under "Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2026-2027-Q1-1044103 | York University | FY2027 | $462,000 | FY2027 |
| 172-2026-2027-Q1-1043787 | Simon Fraser University | FY2027 | $279,766 | FY2027 |
| 172-2026-2027-Q1-1044229 | Noram Electrolysis Systems Inc. | FY2027 | $300,053 | FY2027 |
| 172-2026-2027-Q1-1043305 | University of Ottawa | FY2027 | $418,000 | FY2027 |
| 172-2026-2027-Q1-1043602 | University of Windsor | FY2027 | $99,000 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2021-2022-Q2-992466 · retrieved 2026-11-14.